Serum metabolic signatures of fulminant type 1 diabetes

Journal of Proteome Research

Volumn 11, Issue 9, 2012, Pages 4705-4711

  Jia, Weiping ^a   Jia, Wei ^b   Lu, Jingyi ^a   Zhou, Jian ^a   Bao, Yuqian ^a   Chen, Tianlu ^a   Zhang, Yinan ^a   Zhao, Aihua ^a   Qiu, Yunping ^b   Xie, Guoxiang ^b   Wang, Congrong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

biomarker; FT1DM; fulminant type 1 diabetes; metabolomics; metabonomics; serum

Indexed keywords

BIOLOGICAL MARKER; GLUTAMIC ACID; HOMOCYSTEINE; PYROGLUTAMIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; FULMINANT TYPE 1 DIABETES MELLITUS; GAS CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AMINO ACIDS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTATHIONE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS;

EID: 84866133036     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300523x     Document Type: Article

References (27)

1. Imagawa, A.; Hanafusa, T.; Miyagawa, J.; Matsuzawa, Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group N. Engl. J. Med. 2000, 342 (5) 301-307 (Pubitemid 30075242)
2. Sayama, K.; Imagawa, A.; Okita, K.; Uno, S.; Moriwaki, M.; Kozawa, J.; Iwahashi, H.; Yamagata, K.; Tamura, S.; Matsuzawa, Y.; Hanafusa, T.; Miyagawa, J.; Shimomura, I. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment Diabetologia 2005, 48 (8) 1560-1564 (Pubitemid 41175509)
3. Hanafusa, T.; Imagawa, A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners Nat. Clin. Pract. Endocrinol. Metab. 2007, 3 (1) 36-45 (Pubitemid 46006611)
4. Murao, S.; Makino, H.; Kaino, Y.; Konoue, E.; Ohashi, J.; Kida, K.; Fujii, Y.; Shimizu, I.; Kawasaki, E.; Fujiyama, M.; Kondo, S.; Tanaka, K.; Tarumi, Y.; Seto, I.; Kato, K.; Ohno, K.; Kusunoki, Y.; Ebisui, O.; Takada, Y.; Tanabe, K.; Takemoto, K.; Onuma, H.; Nishimiya, T.; Osawa, H. Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients Diabetes 2004, 53 (10) 2684-2690 (Pubitemid 39299279)
5. Moreau, C.; Drui, D.; Arnault-Ouary, G.; Charbonnel, B.; Chaillous, L.; Cariou, B. Fulminant type 1 diabetes in Caucasians: A report of three cases Diabetes Metab. 2008, 34 (5) 529-532
6. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
7. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-4850
8. Lanza, I. R.; Zhang, S.; Ward, L. E.; Karakelides, H.; Raftery, D.; Nair, K. S. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes PLoS One 2010, 5 (5) e10538
9. Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma Mol. Cell. Proteomics 2011, 10 (7) M110 004945
10. Bernini, P.; Bertini, I.; Luchinat, C.; Tenori, L.; Tognaccini, A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples J. Proteome Res. 2011, 10 (11) 4983-4992
11. Xie, G. X.; Zheng, X. J.; Qi, X.; Cao, Y.; Chi, Y.; Su, M. M.; Ni, Y.; Qiu, Y. P.; Liu, Y. M.; Li, H. K.; Zhao, A. H.; Jia, W. Metabonomic evaluation of melamine-induced acute renal toxicity in rats J. Proteome Res. 2010, 9 (1) 125-133
12. Alberti, K. G.; Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Med. 1998, 15 (7) 539-553 (Pubitemid 28319935)
13. Jia, W. P.; Pang, C.; Chen, L.; Bao, Y. Q.; Lu, J. X.; Lu, H. J.; Tang, J. L.; Wu, Y. M.; Zuo, Y. H.; Jiang, S. Y.; Xiang, K. S. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities Diabetologia 2007, 50 (2) 286-292
14. Bao, Y.; Zhao, T.; Wang, X.; Qiu, Y.; Su, M.; Jia, W. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers J. Proteome Res. 2009, 8 (4) 1623-1630
15. Jonsson, P.; Gullberg, J.; Nordstrom, A.; Kusano, M.; Kowalczyk, M.; Sjostrom, M.; Moritz, T. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS Anal. Chem. 2004, 76 (6) 1738-1745 (Pubitemid 38338423)
16. Jonsson, P.; Johansson, A. I.; Gullberg, J.; Trygg, J.; A, J.; Grung, B.; Marklund, S.; Sjostrom, M.; Antti, H.; Moritz, T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses Anal. Chem. 2005, 77 (17) 5635-5642 (Pubitemid 41268639)
17. Jansson, J.; Willing, B.; Lucio, M.; Fekete, A.; Dicksved, J.; Halfvarson, J.; Tysk, C.; Schmitt-Kopplin, P. Metabolomics reveals metabolic biomarkers of Crohn's disease PLoS One 2009, 4 (7) e6386
18. Yamanouchi, T.; Tachibana, Y.; Akanuma, H.; Minoda, S.; Shinohara, T.; Moromizato, H.; Miyashita, H.; Akaoka, I. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body Am. J. Physiol. 1992, 263 (2 Pt 1) E268-273
19. Yamanouchi, T.; Akanuma, H.; Asano, T.; Konishi, C.; Akaoka, I.; Akanuma, Y. Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus Diabetes 1987, 36 (6) 709-715 (Pubitemid 17141109)
20. Stettler, C.; Stahl, M.; Allemann, S.; Diem, P.; Schmidlin, K.; Zwahlen, M.; Riesen, W.; Keller, U.; Christ, E. Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients Diabetes Care 2008, 31 (8) 1534-1535
21. Yamanouchi, T.; Ogata, N.; Tagaya, T.; Kawasaki, T.; Sekino, N.; Funato, H.; Akaoka, L.; Miyashita, H. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control Lancet 1996, 347 (9014) 1514-1518 (Pubitemid 26162642)
22. Krebs, H. A.; Henseleit, K. Untersuchungen uber die harnstoffbildung im tierkorper Hoppe-Seyler's Z. Physiol. Chem. 1932, 210, 325-332
23. Soga, T.; Baran, R.; Suematsu, M.; Ueno, Y.; Ikeda, S.; Sakurakawa, T.; Kakazu, Y.; Ishikawa, T.; Robert, M.; Nishioka, T.; Tomita, M. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption J. Biol. Chem. 2006, 281 (24) 16768-16776
24. Mosharov, E.; Cranford, M. R.; Banerjee, R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes Biochemistry 2000, 39 (42) 13005-13011
25. Persa, C.; Pierce, A.; Ma, Z.; Kabil, O.; Lou, M. F. The presence of a transsulfuration pathway in the lens: a new oxidative stress defense system Exp. Eye Res. 2004, 79 (6) 875-886 (Pubitemid 40092279)
26. Meister, A.; Larsson, A., Glutathione Synthetase Deficiency, 1 ed.; McGraw-Hill: New York, 1989; Vol. I.
27. Suhre, K.; Meisinger, C.; Doring, A.; Altmaier, E.; Belcredi, P.; Gieger, C.; Chang, D.; Milburn, M. V.; Gall, W. E.; Weinberger, K. M.; Mewes, H. W.; Hrabe de Angelis, M.; Wichmann, H. E.; Kronenberg, F.; Adamski, J.; Illig, T. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting PLoS One 2010, 5 (11) e13953